PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
|Articles|November 2, 2019
- Pharmaceutical Technology-11-02-2019
- Volume 43
- Issue 11
Powder Dosing Unit
Extrudor by MG America is a new powder dosing unit that only requires one dosing disk per capsule size, regardless of the dosage.
Extrudor by MG America is a new powder dosing unit that only requires one dosing disk per capsule size, regardless of the dosage. The device was designed to work in conjunction with the company’s AlternA70N Intermittent Motion Capsule Filler, which is used for dosing and filling powders and pellets into hard-shell gelatin capsules.
The new unit comes equipped with a redesigned dosing container and disk to simplify the capsule filling process and improve dosing accuracy and weight consistency. It also reduces product wastage by maintaining the powder inside the container and disk to control powder loss, improve yields, and cut down on cleanup time.
Articles in this issue
almost 7 years ago
QbD Takes Shape for Topical Pharmaceuticalsalmost 7 years ago
Optimizing Compression Coating for Pulsatile Release Tabletsalmost 7 years ago
Advancing Transdermal Drug Deliveryalmost 7 years ago
The Emergence of Operational Technology as a Servicealmost 7 years ago
Residual Moisture Determination in Lyophilized Drug Productsalmost 7 years ago
Highest Shear Mixer Availablealmost 7 years ago
Innomech Benchtop Systemsalmost 7 years ago
Automated Cotton Inserteralmost 7 years ago
The Right Pieces for a Quality Programalmost 7 years ago
More Consistent Drug Inspection System on HorizonRelated to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.